Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins

Our knowledge regarding chemical structure and properties of heparin and its derivatives, including biological properties in blood plasma, on the cell surface and while interacting with receptors, has been progressively growing. New insights are followed by the expansion of therapeutic opportunities...

Popoln opis

Bibliografske podrobnosti
Main Authors: V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, N. V. Pyatigorskaya, S. V. Akinshina, N. A. Makatsariya, K. E. Gotsiridze, N. N. Babaeva, K. N. Grigoreva, A. S. Shkoda, I. Elalamy, J.-C. Gris, S. Shulman
Format: Article
Jezik:Russian
Izdano: IRBIS LLC 2021-07-01
Serija:Акушерство, гинекология и репродукция
Teme:
Online dostop:https://www.gynecology.su/jour/article/view/1010
_version_ 1826567117123616768
author V. O. Bitsadze
E. V. Slukhanchuk
J. Kh. Khizroeva
M. V. Tretyakova
N. V. Pyatigorskaya
S. V. Akinshina
N. A. Makatsariya
K. E. Gotsiridze
N. N. Babaeva
K. N. Grigoreva
A. S. Shkoda
I. Elalamy
J.-C. Gris
S. Shulman
author_facet V. O. Bitsadze
E. V. Slukhanchuk
J. Kh. Khizroeva
M. V. Tretyakova
N. V. Pyatigorskaya
S. V. Akinshina
N. A. Makatsariya
K. E. Gotsiridze
N. N. Babaeva
K. N. Grigoreva
A. S. Shkoda
I. Elalamy
J.-C. Gris
S. Shulman
author_sort V. O. Bitsadze
collection DOAJ
description Our knowledge regarding chemical structure and properties of heparin and its derivatives, including biological properties in blood plasma, on the cell surface and while interacting with receptors, has been progressively growing. New insights are followed by the expansion of therapeutic opportunities and indications for the use of heparins. There are prerequisites for the creation of new generation drugs with modified properties that reduce a bleeding risk while applied for a non-anticoagulant goal. The non-anticoagulant heparin properties allow to consider it as a candidate for pathogenetic treatment of patients with COVID-19. This review focuses on the anticoagulant and non-anticoagulant heparin properties as well as the underlying molecular mechanisms.
first_indexed 2024-04-10T04:02:06Z
format Article
id doaj.art-d654faae92e446029f925fc0c49d461f
institution Directory Open Access Journal
issn 2313-7347
2500-3194
language Russian
last_indexed 2025-03-14T11:02:26Z
publishDate 2021-07-01
publisher IRBIS LLC
record_format Article
series Акушерство, гинекология и репродукция
spelling doaj.art-d654faae92e446029f925fc0c49d461f2025-03-02T10:43:06ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942021-07-0115329531210.17749/2313-7347/ob.gyn.rep.2021.216654Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparinsV. O. Bitsadze0E. V. Slukhanchuk1J. Kh. Khizroeva2M. V. Tretyakova3N. V. Pyatigorskaya4S. V. Akinshina5N. A. Makatsariya6K. E. Gotsiridze7N. N. Babaeva8K. N. Grigoreva9A. S. Shkoda10I. Elalamy11J.-C. Gris12S. Shulman13Sechenov UniversityPetrovsky National Research Centre of SurgerySechenov University«Medical Center» LLCSechenov UniversitySechenov UniversitySechenov UniversityChachava Clinic«Altamed+» LLCSechenov UniversityVorokhobov City Clinical Hospital № 67, Moscow Healthcare DepartmentSechenov University; Medicine Sorbonne University; Hospital TenonSechenov University; University of MontpellierMcMaster University; Hamilton General Hospital; Karolinska InstituteOur knowledge regarding chemical structure and properties of heparin and its derivatives, including biological properties in blood plasma, on the cell surface and while interacting with receptors, has been progressively growing. New insights are followed by the expansion of therapeutic opportunities and indications for the use of heparins. There are prerequisites for the creation of new generation drugs with modified properties that reduce a bleeding risk while applied for a non-anticoagulant goal. The non-anticoagulant heparin properties allow to consider it as a candidate for pathogenetic treatment of patients with COVID-19. This review focuses on the anticoagulant and non-anticoagulant heparin properties as well as the underlying molecular mechanisms.https://www.gynecology.su/jour/article/view/1010heparinanticoagulantsmetastasesinflammationcovid-19
spellingShingle V. O. Bitsadze
E. V. Slukhanchuk
J. Kh. Khizroeva
M. V. Tretyakova
N. V. Pyatigorskaya
S. V. Akinshina
N. A. Makatsariya
K. E. Gotsiridze
N. N. Babaeva
K. N. Grigoreva
A. S. Shkoda
I. Elalamy
J.-C. Gris
S. Shulman
Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
Акушерство, гинекология и репродукция
heparin
anticoagulants
metastases
inflammation
covid-19
title Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
title_full Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
title_fullStr Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
title_full_unstemmed Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
title_short Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
title_sort anticoagulant anti inflammatory antiviral and antitumor properties of heparins
topic heparin
anticoagulants
metastases
inflammation
covid-19
url https://www.gynecology.su/jour/article/view/1010
work_keys_str_mv AT vobitsadze anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT evslukhanchuk anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT jkhkhizroeva anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT mvtretyakova anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT nvpyatigorskaya anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT svakinshina anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT namakatsariya anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT kegotsiridze anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT nnbabaeva anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT kngrigoreva anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT asshkoda anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT ielalamy anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT jcgris anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins
AT sshulman anticoagulantantiinflammatoryantiviralandantitumorpropertiesofheparins